Alexion Canada News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alexion canada. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alexion Canada Today - Breaking & Trending Today

Alexion Canada Appoints Karen Heim as New General Manager

Alexion Pharma Canada Corp., AstraZeneca's Rare Disease group, is pleased to announce the appointment of Karen Heim as Vice President and General Manager, Canada, effective April 1st, 2024. In this role, Ms. Heim will lead the Canadian affiliate in its unwavering commitment to helping people affected by rare diseases live longer, healthier lives. ....

United States , Soraya Bekkali , International Regions At Alexion , Alexion Pharmaceuticals Inc , Alexion Development Hub For Rare Diseases , Queen University , Senior Vice President , International Regions , Alexion Canada , Global Commercial Vice President , Patient Access , Established Brands , Metallurgical Engineering , Professional Engineering License , Astrazeneca Rare Disease , Alexion Pharmaceuticals , Rare Disease , Astrazeneca Rd Hub , Alexion Development Hub ,

KOSELUGOtm approved in Canada for pediatric patients with neurofibromatosis type 1 (NF1) plexiform neurofibromas (PN)

Alexion, AstraZeneca Rare Disease, today announced that Health Canada has granted a Notice of Compliance (NOC) for KOSELUGO (selumetinib) for the treatment of pediatric patients aged two years and above, with neurofibromatosis type 1 (NF1) who have. ....

United States , South Korea , Clin Genet , Gaby Bourbara , Alexion Pharmaceuticals Inc , Neurofibromatosis Therapeutic Acceleration Program , National Institute Of Neurological Disorders , Pediatric Oncology Branch , Cancer Research , Children Tumor Foundation , Health Canada , Quebec Neurofibromatosis Association , Astrazeneca Canada Inc , National Cancer Institute , Cancer Therapy Evaluation Program , Development Agreement , Astrazeneca Rare Disease , Pediatric Oncology , Alexion Canada , Cooperative Research , Orphan Drug Designation , Alexion Pharmaceuticals , Rare Disease , Astrazeneca Canada , Tumor Foundation , Accessed February ,